Chemotherapy of testicular cancer
Block, N.L.
Journal of the Florida Medical Association 61(11): 817-820
1974
ISSN/ISBN: 0015-4148 PMID: 4473010 Document Number: 81439
Document emailed within 1 workday
Related Documents
Sternberg, C.N.; Bosl, G.J. 1988: Advances in testicular cancer--role of chemotherapy Progress in Clinical and Biological Research 277: 79-84Tan, Y.O. 1984: Chemotherapy of disseminated testicular cancer--a Singapore experience Annals of the Academy of Medicine Singapore 13(4): 625-629
Hansen, L.J.; Madsen, E.L.; Møller, M.N. 1993: Benign enlargement of the thymus after chemotherapy of metastasizing testicular cancer Ugeskrift for Laeger 155(15): 1141-1142
Miki, T.; Saki, S.; Kotake, T. 1994: The role of salvage surgery following chemotherapy in advanced testicular cancer Hinyokika Kiyo. Acta Urologica Japonica 40(10): 951-955
Fossa, S.D.; Paus, E. 1985: Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer Progress in Clinical and Biological Research 203: 121
Gallmeier, W.M.; Kaiser, G.; Bruntsch, U. 1984: Chemotherapy of non-seminoma testicular cancer. Chances of recovery in a metastasizing malignant tumor Münchener Medizinische Wochenschrift 126(2): 14-19
Einhorn, L.H.; Williams, S.D. 1978: Combination chemotherapy with cis-dichlorodiammineplatinum(II) and adriamycin for testicular cancer refractory to vinblastine plus bleomycin Cancer Treatment Reports 62(9): 1351-1353
Hida, S.; Kawakita, M.; Oishi, K.; Okada, Y.; Takeuchi, H.; Okada, K.; Yoshida, O. 1986: False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer Hinyokika Kiyo. Acta Urologica Japonica 32(12): 1859-1866
Shoji, S.; Miyakita, H.; Shima, M.; Usui, Y.; Nagata, Y.; Uchida, T.; Terachi, T. 2006: Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer Hinyokika Kiyo. Acta Urologica Japonica 52(9): 723-726
Ondrus, D.; Hornák, M.; Matoska, J. 1993: Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer Neoplasma 40(3): 189-192
Blokzijl, E.; Janssens, P.M.W. 2007: Treatment of testicular cancer clinical stage I: watchful waiting, radiotherapy, chemotherapy or surgical intervention Nederlands Tijdschrift Voor Geneeskunde 151(8): 502-503
Ozet, A.; Yavuz, A.A.; Oztürk, B.; Kömürcü, S.; Arpaci, F.; Tuvay, E.; Tezcan, Y. 2000: Recurrent spontaneous pneumothorax following high-dose chemotherapy in a patient with non-seminomatous testicular cancer with pulmonary metastases Tumori 86(3): 253-255
Fernández-Miranda, C.; Schoebel, N.; Angulo, A.; Paz-Ares, L.; Lianes, P.; del Palacio, A. 1997: Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy Revista Clinica Espanola 197(7): 490-493
Nonomura, N.; Imazu, T.; Harada, Y.; Nozawa, M.; Ono, Y.; Fukui, T.; Nishimura, K.; Okuyama, A. 1999: Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes Hinyokika Kiyo. Acta Urologica Japonica 45(8): 593-597
Mikami, K.; Nakagawa, S.; Sugimoto, K.; Nomoto, T.; Urano, S.; Watanabe, H.; Iwamoto, N.; Yamazaki, S.; Hiratake, Y.; Maegawa, M. 1997: Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria Hinyokika Kiyo. Acta Urologica Japonica 43(8): 561-566
Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Ishii, H.; Osa, Y.; Okano, T.; Isaka, S.; Yasuda, K.; Shimazaki, J.; Komori, I.; Kodo, H.; Asano, S. 1989: A case of refractory testicular cancer showing complete response to high-dose chemotherapy with autologous bone marrow transplantation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(10): 3483-3486
Solé-Balcells, F.; Villavicencio, H.; Germá, R. 1989: Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed? Progress in Clinical and Biological Research 303: 759-762
King, B.L.; Peng, H.Q.; Goss, P.; Huan, S.; Bronson, D.; Kacinski, B.M.; Hogg, D. 1997: Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors, and testicular cancer families Cancer Research 57(2): 209-214
Rorth, M. 1985: Non-seminomatous testicular cancer stage I. Orchiectomy alone versus orchiectomy + radiotherapy: a randomized study by the Danish Testicular Cancer Study Group Progress in Clinical and Biological Research 203: 561